ARIAD PHARMACEUTICALS INC's ticker is ARIA and the CUSIP is 04033A100. A total of 1 filers reported holding ARIAD PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 2.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $4,670,000 | +25.3% | 375,402 | +37.9% | 0.00% | +50.0% |
| Q3 2016 | $3,727,000 | +142.2% | 272,242 | +30.8% | 0.00% | +100.0% |
| Q2 2016 | $1,539,000 | +91.7% | 208,176 | +65.7% | 0.00% | 0.0% |
| Q1 2016 | $803,000 | -74.9% | 125,645 | -75.5% | 0.00% | -50.0% |
| Q4 2015 | $3,199,000 | +129.2% | 511,863 | +114.2% | 0.00% | +100.0% |
| Q3 2015 | $1,396,000 | -34.7% | 238,998 | -7.6% | 0.00% | 0.0% |
| Q2 2015 | $2,139,000 | +13.6% | 258,702 | +13.2% | 0.00% | 0.0% |
| Q1 2015 | $1,883,000 | -24.3% | 228,621 | -36.8% | 0.00% | 0.0% |
| Q4 2014 | $2,486,000 | – | 361,708 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 12,850,000 | $175,916,000 | 40.51% |
| Consonance Capital Management LP | 8,695,742 | $119,045,000 | 11.46% |
| Tamarack Advisers, LP | 3,700,000 | $49,358,000 | 7.76% |
| Opaleye Management Inc. | 1,045,000 | $14,306,000 | 7.49% |
| Granite Point Capital Management, L.P. | 457,415 | $6,262,000 | 2.44% |
| Redmile Group, LLC | 2,138,471 | $29,276,000 | 2.33% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 206,010 | $2,820,000 | 2.17% |
| Palo Alto Investors LP | 2,587,617 | $35,424,000 | 2.06% |
| PRICE MICHAEL F | 940,000 | $12,869,000 | 1.71% |
| HighVista Strategies LLC | 638,086 | $8,735,000 | 1.62% |